Advocating for a world where intellectual
property law serves the public interest.

Sen. Wyden: “NAFTA 2.0 Must Take a Balanced Approach to Copyright”

Inside U.S. Trade reports on a Capitol Hill event on digital trade and the NAFTA renegotation at which Sen. Wyden made the following remark regarding copyright: “NAFTA 2.0 must take a balanced approach to copyright that ensures the free flow of ideas around the world and allows American companies to continue to compete and win […]

New Report: Weakened Intermediary Liability Protections Will Cost 4.25 Million Jobs & Nearly Half A Trillion Dollars In Next Decade

Internet Association Press Release, June 29, 2017. Link (CC-BY-NC-SA) Today, Internet Association released a new analysis that found reducing intermediary liability safe harbor protections would cost the U.S. 4.25 million jobs and reduce GDP by nearly half a trillion dollars over the next decade. Conducted by NERA Economic Consulting, the report represents the first quantitative […]

EU Parliament Adopts Marrakesh Treaty; Blind Union Prepared To Fight Publisher ‘Compensation’

Monika Ermert, IP-Watch, Link (CC-BY-NC-SA) The European Parliament today with over 600 votes adopted the legal instruments to ratify the Marrakesh Treaty on access to reading material for the visually impaired. The treaty, adopted by the members of the World Intellectual Property Organization in 2013 and effective since last year, has been subject of controversies […]

Drug Price Gouging: Int’l Union of Operating Engineers Stationary Engineers Local 39 Health & Welfare Trust Fund et al v. Celgene

[PIJIP Staff] On June 14th, 2017, the International Union of Operating Engineers Stationary Engineers Local 39 Health and Welfare Trust Fund, The Detectives’ Endowment Association, Inc., and David Mitchell (“Plaintiffs”) filed a class action antitrust complaint against Celgene Corporation (“Celgene”) over Celgene’s alleged exclusion of competition from the market for two drugs: thalidomide and lenalidomide. […]

Canada Blinks in Face of US/Pharma Pressure

Supreme Court Adopts Wink-Wink Patent Utility Rule In a stunning reversal of policy, on June 30, 2017, the Supreme Court of Canada overturned decades of precedent making it easier for the biopharmaceutical industry to gain patents on medicines without any real proof of a claim that a putative invention has any meaningful utility. This reversal […]

The Trump Administration Invites Public Comment for Review of Existing Trade Agreements

Today, the Office of the U.S. Trade Representative announced a request for public input for a performance review of all the United States’ existing international trade and investment agreements. In an April 29, 2017 executive order, President Trump directed USTR and the Department of Commerce to submit within 180 days a report that reviews trade agreement […]